Mutation analysis of the PINK1 gene in 391 patients with Parkinson disease

Archives of Neurology

Volumn 65, Issue 6, 2008, Pages 802-808

  Kumazawa, Ryuya ^a   Tomiyama, Hiroyuki ^a   Li, Yuanzhe ^a   Imamichi, Yoko ^a   Funayama, Manabu ^a   Yoshino, Hiroyo ^a   Yokochi, Fusako ^b   Fukusako, Toshihiro ^c   Takehisa, Yasushi ^d   Kashihara, Kenichi ^e   Kondo, Tomoyoshi ^f   Elibol, Bulent ^g   Bostantjopoulou, Sevasti ^h   Toda, Tatsushi ⁱ   Takahashi, Hirohide ^j   Yoshii, Fumihito ^j   Mizuno, Yoshikuni ^a   Hattori, Nobutaka ^a,i  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKYO METROPOLITAN NEUROLOGICAL HOSPITAL   (Japan)

^c Yamaguchi Grand Medical Center   (Japan)

^d OKAYAMA UNIVERSITY   (Japan)

^e OKAYAMA KYOKUTO HOSPITAL   (Japan)

^f WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^g HACETTEPE UNIVERSITY   (Turkey)

^h G PAPANICOLAOU HOSPITAL   (Greece)

ⁱ JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^j TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123;

ADULT; ARTICLE; AUTOSOMAL RECESSIVE INHERITANCE; CLINICAL FEATURE; DNA DETERMINATION; FEMALE; GENE; GENE MUTATION; GENETIC ANALYSIS; GENETIC PREDISPOSITION; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATION RATE; PARKINSON DISEASE; PINK1 GENE; PRIORITY JOURNAL; SCINTIGRAPHY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; DNA MUTATIONAL ANALYSIS; FEMALE; HETEROZYGOTE DETECTION; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; PEDIGREE; PROTEIN KINASES; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 45149111328     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.65.6.802     Document Type: Article

References (32)

1. Lang AE, Lozano AM. Parkinson's disease: second of two parts. N Engl J Med. 1998;339(16):1130-1143.
2. Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the alphasynuclein gene identified in families with Parkinson's disease. Science. 1997;276(5321):2045-2047.
3. Leroy E, Boyer R, Auburger G, et al. The ubiquitin pathway in Parkinson's disease. Nature. 1998;395(6701):451-452.
4. Harhangi BS, Farrer MJ, Lincoln S, et al. The Ile93Met mutation in the ubiquitin carboxy-terminal-hydrolase-L1 gene is not observed in European cases with familial Parkinson's disease. Neurosci Lett. 1999;270(1):1-4.
5. Paisán-Ruíz C, Jain S, Evans EW, et al. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron. 2004;44(4):595-600.
6. Zimprich A, Biskup S, Leitner P, et al. Mutations in LRRK2 cause autosomal dominant parkinsonism with pleomorphic pathology. Neuron. 2004;44(4):601-607.
7. Kitada T, Asakawa S, Hattori N, et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature. 1998;392(6676):605- 608.
8. Bonifati V, Rizzu P, van Baren MJ, et al. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science. 2003;299(5604):256-259.
9. Valente EM, Abou-Sleiman PM, Caputo V, et al. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science. 2004;304(5674):1158-1160.
10. Lücking CB, Durr A, Bonifati V, et al. Association between early-onset Parkinson's disease and mutations in the parkin gene. N Engl J Med. 2000;342(21):1560-1567.
11. Hattori N, Mizuno Y. Pathogenetic mechanisms of parkin in Parkinson's disease. Lancet. 2004;364(9435):722-724.
12. Groen JL, Kawarai T, Toulina A, et al. Genetic association study of PINK1 coding polymorphisms in Parkinson's disease. Neurosci Lett. 2004;372(3):226-229.
13. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992;55(3):181-184.
14. Hatano Y, Li Y, Sato K, et al. Novel PINK1 mutations in early-onset parkinsonism. Ann Neurol. 2004;56(3):424-427.
15. Li Y, Tomiyama H, Sato K, et al. Clinicogenetic study of PINK1 mutations in autosomal recessive early-onset parkinsonism. Neurology. 2005;64(11):1955-1957.
16. Zhang YH, Tang BS, Guo JF, et al. Mutation analysis of PINK1 gene in Chinese patients with autosomal recessive early-onset parkinsonism type 6. Zhonghua Yi Xue Za Zhi. 2005;85(22):1538-1541.
17. Hatano Y, Sato K, Elibol B, et al. PARK6-linked autosomal recessive early-onset parkinsonism in Asian. Neurology. 2004;63(8):1482-1485.
18. Abou-Sleiman PM, Healy DG, Quinn N, Lees AJ, Wood NW. The role of pathogenic DJ-1 mutations in Parkinson's disease. Ann Neurol. 2003;54(3):283-286.
19. Ibáñez P, De Michele G, Bonifati V, et al. Screening for DJ-1 mutations in early onset autosomal recessive parkinsonism. Neurology. 2003;61(10):1429-1431.
20. Ibáñez P, Lesage S, Lohmann E, et al. Mutational analysis of the PINK1 gene in early-onset parkinsonism in Europe and North Africa. Brain. 2006;129(pt 3):686-694.
21. Valente EM, Salvi S, Ialongo T, et al. PINK1 mutations are associated with sporadic early-onset parkinsonism. Ann Neurol. 2004;56(3):336-341.
22. Abou-Sleiman PM, Muqit M, McDonald N, et al. A heterozygous effect for PINK1 mutations in Parkinson's disease? Ann Neurol. 2006;60(4):414-419.
23. Rogaeva E, Johnson J, Lang AE, et al. Analysis of the PINK1 gene in a large cohort of cases with Parkinson disease. Arch Neurol. 2004;61(12):1898-1904.
24. Khan NL, Valente EM, Bentiboqlio AR, et al. Clinical and subclinical dopaminergic dysfunction in PARK6-linked parkinsonism: an 18F-dopa PET study. Ann Neurol. 2002;52(6):849-853.
25. 123I- metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease. J Neurol Neurosurg Psychiatry. 1999;67(2):189-194.
26. Orimo S, Amino T, Itoh Y, et al. Cardiac sympathetic denervation precedes neuronal loss in the sympathetic ganglia in Lewy body disease. Acta Neuropathol. 2005;109(6):583-588.
27. 123I]metaiodobenzylguanidine uptake in autosomal recessive juvenile parkinsonism: first case report. Mov Disord. 2005;20(5):634-636.
28. Kitami T, Nomoto T, Nagao T, et al. 123I-MIBG myocardial scintigraphy in juvenile parkinsonism. Mov Disord. 1998;13(suppl 2):247.
29. Orimo S, Amino T, Yokochi M, et al. Preserved cardiac sympathetic nerve accounts for normal cardiac uptake of MIBG in PARK2. Mov Disord. 2005;20(10):1350-1353.
30. Nagayama H, Hamamoto M, Ueda M, Nagashima J, Katayama Y. Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson's disease. J Neurol Neurosurg Psychiatry. 2005;76(2):249-251.
31. Albanese A, Valente EM, Romito LM, Bellacchio E, Elia AE, Dallapiccola B. The PINK1 phenotype can be indistinguishable from idiopathic Parkinson disease. Neurology. 2005;64(11):1958-1960.
32. Pramstaller PP, Schlossmacher MG, Jacques TS, et al. Lewy body Parkinson's disease in a large pedigree with 77 Parkin mutation carriers. Ann Neurol. 2005;58(3):411-422.